Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

Author(s):
Eggink, F.A.; Gool, I.C. van; Leary, A.; Pollock, P.M.; Crosbie, E.J.; Mileshkin, L.; Jordanova, E.S. (0000-0002-8121-1322); Adam, J.; Freeman-Mills, L.; Church, D.N.; Creutzberg, C.L. (0000-0002-7008-4321); Bruyn, M. de; Nijman, H.W.; Bosse, T.
Published
2017
Publication type
Article / Letter to editor
Checkpoint inhibitionendometrial cancerhigh-riskmolecular classificationtumor-infiltrating lymphocytes
Date issued
2017-12-31
Language
English
Is part of
OncoImmunology (2017), No. 2
hdl
1887/114919
doi
10.1080/2162402X.2016.1264565